An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II
Clinical trial NCT05754450 · RECRUITING
Trial details
- NCT number
- NCT05754450
- Sponsor
- AUG Therapeutics
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-10
- Primary completion
- 2026-12-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.